Anne Clem Whitaker

Anne Clem Whitaker has an estimated net worth of $259 Million. This is based on reported shares across multiple companies, which include Valeant Pharmaceuticals International, Inc., SYNTA PHARMACEUTICALS CORP, CREE, INC., ORASURE TECHNOLOGIES INC, Mallinckrodt plc, Caladrius Biosciences, Inc., and ICON PLC.

2014 was Anne Clem Whitaker's most active year for acquiring shares with 9 total transactions. Anne Clem Whitaker's most active month to acquire stocks was the month of August. 2020 was Anne Clem Whitaker's most active year for disposing of shares, totalling 5 transactions. Anne Clem Whitaker's most active month to dispose stocks was the month of April. 2015 saw Anne Clem Whitaker paying a total of $1,778,730.11 for 234,682 shares, this is the most they've acquired in one year. In 2020 Anne Clem Whitaker cashed out on 63,064 shares for a total of $2,015,560.91, their largest year based on trade value.